1. Home
  2. CALX vs KRYS Comparison

CALX vs KRYS Comparison

Compare CALX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALX
  • KRYS
  • Stock Information
  • Founded
  • CALX 1999
  • KRYS 2015
  • Country
  • CALX United States
  • KRYS United States
  • Employees
  • CALX N/A
  • KRYS N/A
  • Industry
  • CALX Telecommunications Equipment
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CALX Consumer Discretionary
  • KRYS Health Care
  • Exchange
  • CALX Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • CALX 4.2B
  • KRYS 4.7B
  • IPO Year
  • CALX 2010
  • KRYS 2017
  • Fundamental
  • Price
  • CALX $59.34
  • KRYS $182.55
  • Analyst Decision
  • CALX Strong Buy
  • KRYS Strong Buy
  • Analyst Count
  • CALX 5
  • KRYS 9
  • Target Price
  • CALX $64.00
  • KRYS $203.22
  • AVG Volume (30 Days)
  • CALX 520.5K
  • KRYS 372.8K
  • Earning Date
  • CALX 10-29-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • CALX N/A
  • KRYS N/A
  • EPS Growth
  • CALX N/A
  • KRYS 36.22
  • EPS
  • CALX N/A
  • KRYS 4.91
  • Revenue
  • CALX $869,193,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • CALX $17.57
  • KRYS $34.33
  • Revenue Next Year
  • CALX $10.16
  • KRYS $47.84
  • P/E Ratio
  • CALX N/A
  • KRYS $37.31
  • Revenue Growth
  • CALX N/A
  • KRYS 116.08
  • 52 Week Low
  • CALX $28.61
  • KRYS $122.80
  • 52 Week High
  • CALX $64.30
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • CALX 43.80
  • KRYS 74.86
  • Support Level
  • CALX $58.82
  • KRYS $158.08
  • Resistance Level
  • CALX $61.79
  • KRYS $186.75
  • Average True Range (ATR)
  • CALX 1.53
  • KRYS 6.03
  • MACD
  • CALX -0.51
  • KRYS 1.57
  • Stochastic Oscillator
  • CALX 2.19
  • KRYS 87.73

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: